Medicure (MCUJF) Total Liabilities (2009 - 2026)
Medicure's (MCUJF) quarterly Total Liabilities came in at $7.8 million in Q1 2026, up 15.75% year-on-year from $6.7 million in Q1 2025, and down 9.53% quarter-over-quarter from $8.6 million in Q4 2025.
Medicure (MCUJF) Total Liabilities (2009 - 2026) Analysis & Trends
Medicure's Total Liabilities history runs 18 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- On a quarterly basis, Total Liabilities rose 15.75% year-over-year to $7.8 million in Q1 2026; TTM through Mar 2026 was $7.8 million, a 15.75% increase from a year earlier, with the FY2025 full-year figure at $8.6 million, up 32.55% from the prior year.
- Total Liabilities slipped to $7.8 million in Q1 2026 per MCUJF's latest filing, from $8.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $8.9 million in Q2 2022 and bottomed at $5.2 million in Q3 2023.
- The 5-year median for Total Liabilities is $6.6 million (2025), against an average of $6.8 million.
- Across the five-year window, Total Liabilities slumped 33.82% in 2022 and soared 35.5% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $6.6 million in 2022, then declined by 8.48% to $6.0 million in 2023, then advanced by 6.27% to $6.4 million in 2024, then soared by 35.5% to $8.6 million in 2025, then slipped by 9.53% to $7.8 million in 2026.
- Per Business Quant, the three latest MCUJF Total Liabilities figures stand at $7.8 million (Q1 2026), $8.6 million (Q4 2025), and $6.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 7.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.81 Mn |
| Dec 31, 2025 | 8.63 Mn |
| Sep 30, 2025 | 6.84 Mn |
| Jun 30, 2025 | 7.29 Mn |
| Mar 31, 2025 | 6.75 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Sep 30, 2024 | 6.24 Mn |
| Jun 30, 2024 | 6.36 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Sep 30, 2023 | 5.21 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 6.55 Mn |
| Sep 30, 2022 | 6.90 Mn |
| Jun 30, 2022 | 8.88 Mn |
| Mar 31, 2022 | 7.49 Mn |
| Dec 31, 2021 | 7.93 Mn |
| Sep 30, 2021 | 10.43 Mn |
| Jun 30, 2021 | 11.15 Mn |
| Mar 31, 2021 | 11.00 Mn |